nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—Prostanoid ligand receptors—PTGER4—Crohn's disease	0.0678	0.0809	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostanoid ligand receptors—PTGER4—Crohn's disease	0.0664	0.0792	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Eicosanoid ligand-binding receptors—PTGER4—Crohn's disease	0.0451	0.0538	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Eicosanoid ligand-binding receptors—PTGER4—Crohn's disease	0.0441	0.0526	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Small Ligand GPCRs—PTGER4—Crohn's disease	0.0373	0.0445	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Small Ligand GPCRs—PTGER4—Crohn's disease	0.0365	0.0436	CbGpPWpGaD
Carboprost Tromethamine—Dinoprostone—PTGER4—Crohn's disease	0.0285	0.721	CrCbGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.0259	0.0309	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.0253	0.0302	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—MLN—Crohn's disease	0.0148	0.0177	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—MLN—Crohn's disease	0.0145	0.0173	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.0132	0.0158	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.013	0.0155	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0121	0.0144	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0118	0.0141	CbGpPWpGaD
Carboprost Tromethamine—Tafluprost—PTGS2—Crohn's disease	0.011	0.279	CrCbGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0103	0.0123	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0101	0.0121	CbGpPWpGaD
Carboprost Tromethamine—Hepatic necrosis—Mercaptopurine—Crohn's disease	0.0101	0.0822	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00981	0.0117	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.00977	0.0117	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0096	0.0115	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.00956	0.0114	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GPR65—Crohn's disease	0.00954	0.0114	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GPR65—Crohn's disease	0.00934	0.0111	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00853	0.0102	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00835	0.00997	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00793	0.00947	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ACKR2—Crohn's disease	0.00788	0.0094	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00777	0.00927	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ACKR2—Crohn's disease	0.00771	0.0092	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—MLN—Crohn's disease	0.00747	0.00891	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00738	0.0088	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—MLN—Crohn's disease	0.00731	0.00872	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00722	0.00862	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0068	0.00811	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00665	0.00794	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00632	0.00754	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00619	0.00738	CbGpPWpGaD
Carboprost Tromethamine—Hepatic necrosis—Mesalazine—Crohn's disease	0.00546	0.0446	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00526	0.00627	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR9—Crohn's disease	0.00518	0.00618	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00514	0.00614	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR9—Crohn's disease	0.00507	0.00605	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00493	0.00588	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00483	0.00576	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GPR65—Crohn's disease	0.00481	0.00574	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GPR65—Crohn's disease	0.00471	0.00562	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00463	0.00552	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00453	0.0054	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.0045	0.00537	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00441	0.00526	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00441	0.00526	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00432	0.00515	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—MLN—Crohn's disease	0.00422	0.00504	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—MLN—Crohn's disease	0.00413	0.00493	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ACKR2—Crohn's disease	0.00404	0.00482	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00396	0.00473	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ACKR2—Crohn's disease	0.00396	0.00472	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00388	0.00463	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MLN—Crohn's disease	0.00383	0.00457	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MLN—Crohn's disease	0.00375	0.00448	CbGpPWpGaD
Carboprost Tromethamine—Dysmenorrhoea—Mesalazine—Crohn's disease	0.00349	0.0285	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR6—Crohn's disease	0.00343	0.00409	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR6—Crohn's disease	0.00336	0.00401	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PTGER4—Crohn's disease	0.00302	0.0036	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PTGER4—Crohn's disease	0.00296	0.00353	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR9—Crohn's disease	0.00293	0.00349	CbGpPWpGaD
Carboprost Tromethamine—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00292	0.0238	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR9—Crohn's disease	0.00286	0.00342	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GPR65—Crohn's disease	0.00272	0.00325	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GPR65—Crohn's disease	0.00266	0.00318	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR9—Crohn's disease	0.00266	0.00317	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR9—Crohn's disease	0.0026	0.0031	CbGpPWpGaD
Carboprost Tromethamine—Eye pain—Mesalazine—Crohn's disease	0.00255	0.0208	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GPR65—Crohn's disease	0.00247	0.00295	CbGpPWpGaD
Carboprost Tromethamine—Thirst—Mesalazine—Crohn's disease	0.00242	0.0198	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GPR65—Crohn's disease	0.00242	0.00288	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ACKR2—Crohn's disease	0.00239	0.00285	CbGpPWpGaD
Carboprost Tromethamine—Lethargy—Mesalazine—Crohn's disease	0.00235	0.0192	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ACKR2—Crohn's disease	0.00234	0.00279	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MLN—Crohn's disease	0.00226	0.0027	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00225	0.00269	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MLN—Crohn's disease	0.00222	0.00264	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.0022	0.00263	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00215	0.00256	CbGpPWpGaD
Carboprost Tromethamine—Abdominal pain upper—Mesalazine—Crohn's disease	0.0021	0.0172	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.0021	0.00251	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TAGAP—Crohn's disease	0.00207	0.00247	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TAGAP—Crohn's disease	0.00203	0.00242	CbGpPWpGaD
Carboprost Tromethamine—Asthma—Mesalazine—Crohn's disease	0.00199	0.0163	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR6—Crohn's disease	0.00194	0.00231	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0019	0.0155	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR6—Crohn's disease	0.0019	0.00226	CbGpPWpGaD
Carboprost Tromethamine—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00185	0.0151	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RSPO3—Crohn's disease	0.00181	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RSPO3—Crohn's disease	0.00177	0.00211	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR6—Crohn's disease	0.00176	0.0021	CbGpPWpGaD
Carboprost Tromethamine—Urinary tract infection—Mesalazine—Crohn's disease	0.00173	0.0141	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR6—Crohn's disease	0.00172	0.00206	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SEL1L—Crohn's disease	0.00172	0.00205	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTGER4—Crohn's disease	0.00171	0.00204	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SEL1L—Crohn's disease	0.00168	0.002	CbGpPWpGaD
Carboprost Tromethamine—Hiccups—Prednisone—Crohn's disease	0.00168	0.0137	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Mesalazine—Crohn's disease	0.00167	0.0137	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00167	0.00199	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00165	0.0135	CcSEcCtD
Carboprost Tromethamine—Chills—Azathioprine—Crohn's disease	0.00157	0.0128	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR9—Crohn's disease	0.00157	0.00187	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTGER4—Crohn's disease	0.00155	0.00185	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00154	0.0126	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR9—Crohn's disease	0.00154	0.00183	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTGER4—Crohn's disease	0.00152	0.00181	CbGpPWpGaD
Carboprost Tromethamine—Pulmonary oedema—Prednisone—Crohn's disease	0.00149	0.0122	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Mesalazine—Crohn's disease	0.00149	0.0121	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GPR65—Crohn's disease	0.00146	0.00174	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IL3—Crohn's disease	0.00145	0.00173	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00145	0.00173	CbGpPWpGaD
Carboprost Tromethamine—Chills—Mesalazine—Crohn's disease	0.00143	0.0117	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GPR65—Crohn's disease	0.00143	0.0017	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00143	0.0117	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IL3—Crohn's disease	0.00142	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00142	0.00169	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00141	0.00168	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00138	0.00164	CbGpPWpGaD
Carboprost Tromethamine—Tension—Mesalazine—Crohn's disease	0.00136	0.0111	CcSEcCtD
Carboprost Tromethamine—Nervousness—Mesalazine—Crohn's disease	0.00135	0.011	CcSEcCtD
Carboprost Tromethamine—Back pain—Mesalazine—Crohn's disease	0.00134	0.011	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Mesalazine—Crohn's disease	0.00133	0.0109	CcSEcCtD
Carboprost Tromethamine—Vomiting—Mercaptopurine—Crohn's disease	0.00133	0.0108	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL3—Crohn's disease	0.00132	0.00157	CbGpPWpGaD
Carboprost Tromethamine—Rash—Mercaptopurine—Crohn's disease	0.00132	0.0107	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Mercaptopurine—Crohn's disease	0.00131	0.0107	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Mesalazine—Crohn's disease	0.00131	0.0107	CcSEcCtD
Carboprost Tromethamine—Myalgia—Azathioprine—Crohn's disease	0.0013	0.0106	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL3—Crohn's disease	0.00129	0.00154	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—RASGRP1—Crohn's disease	0.00128	0.00152	CbGpPWpGaD
Carboprost Tromethamine—Angioedema—Mesalazine—Crohn's disease	0.00127	0.0104	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00125	0.00149	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Mesalazine—Crohn's disease	0.00125	0.0102	CcSEcCtD
Carboprost Tromethamine—Syncope—Mesalazine—Crohn's disease	0.00124	0.0102	CcSEcCtD
Carboprost Tromethamine—Lethargy—Prednisone—Crohn's disease	0.00124	0.0102	CcSEcCtD
Carboprost Tromethamine—Nausea—Mercaptopurine—Crohn's disease	0.00124	0.0101	CcSEcCtD
Carboprost Tromethamine—Infection—Azathioprine—Crohn's disease	0.00123	0.0101	CcSEcCtD
Carboprost Tromethamine—Palpitations—Mesalazine—Crohn's disease	0.00123	0.01	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Mesalazine—Crohn's disease	0.00122	0.00996	CcSEcCtD
Carboprost Tromethamine—Cough—Mesalazine—Crohn's disease	0.00121	0.00989	CcSEcCtD
Carboprost Tromethamine—Hypertension—Mesalazine—Crohn's disease	0.0012	0.00978	CcSEcCtD
Carboprost Tromethamine—Chest pain—Mesalazine—Crohn's disease	0.00118	0.00965	CcSEcCtD
Carboprost Tromethamine—Myalgia—Mesalazine—Crohn's disease	0.00118	0.00965	CcSEcCtD
Carboprost Tromethamine—Anxiety—Mesalazine—Crohn's disease	0.00118	0.00961	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00113	0.00925	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Mesalazine—Crohn's disease	0.00113	0.00925	CcSEcCtD
Carboprost Tromethamine—Infection—Mesalazine—Crohn's disease	0.00112	0.00919	CcSEcCtD
Carboprost Tromethamine—Shock—Mesalazine—Crohn's disease	0.00111	0.0091	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Mesalazine—Crohn's disease	0.00111	0.00903	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL8—Crohn's disease	0.00111	0.00132	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.0011	0.00131	CbGpPWpGaD
Carboprost Tromethamine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00109	0.00894	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL8—Crohn's disease	0.00108	0.00129	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.00108	0.00129	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR6—Crohn's disease	0.00104	0.00124	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00103	0.00843	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Prednisone—Crohn's disease	0.00103	0.00838	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IL2RA—Crohn's disease	0.00102	0.00121	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR6—Crohn's disease	0.00102	0.00121	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Mesalazine—Crohn's disease	0.00102	0.0083	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Mesalazine—Crohn's disease	0.00101	0.00824	CcSEcCtD
Carboprost Tromethamine—Somnolence—Mesalazine—Crohn's disease	0.00101	0.00822	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000996	0.00119	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Azathioprine—Crohn's disease	0.000983	0.00803	CcSEcCtD
Carboprost Tromethamine—Pain—Mesalazine—Crohn's disease	0.000968	0.00791	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RBX1—Crohn's disease	0.00094	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL2RA—Crohn's disease	0.000924	0.0011	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RBX1—Crohn's disease	0.00092	0.0011	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Azathioprine—Crohn's disease	0.000916	0.00748	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTGER4—Crohn's disease	0.000915	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL2RA—Crohn's disease	0.000905	0.00108	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTGER4—Crohn's disease	0.000896	0.00107	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Mesalazine—Crohn's disease	0.000895	0.00731	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Azathioprine—Crohn's disease	0.00085	0.00695	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Mesalazine—Crohn's disease	0.000834	0.00681	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—UBE2D1—Crohn's disease	0.000824	0.000984	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Azathioprine—Crohn's disease	0.000822	0.00671	CcSEcCtD
Carboprost Tromethamine—Asthenia—Mesalazine—Crohn's disease	0.000812	0.00664	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—UBE2D1—Crohn's disease	0.000807	0.000963	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RIPK2—Crohn's disease	0.000799	0.000954	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Azathioprine—Crohn's disease	0.00079	0.00646	CcSEcCtD
Carboprost Tromethamine—Rash—Azathioprine—Crohn's disease	0.000784	0.0064	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Azathioprine—Crohn's disease	0.000783	0.0064	CcSEcCtD
Carboprost Tromethamine—Flushing—Prednisone—Crohn's disease	0.000783	0.00639	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RIPK2—Crohn's disease	0.000782	0.000934	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL3—Crohn's disease	0.00078	0.00093	CbGpPWpGaD
Carboprost Tromethamine—Headache—Azathioprine—Crohn's disease	0.000779	0.00636	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Mesalazine—Crohn's disease	0.000775	0.00633	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL3—Crohn's disease	0.000763	0.000911	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RASGRP1—Crohn's disease	0.000754	0.0009	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Mesalazine—Crohn's disease	0.000749	0.00612	CcSEcCtD
Carboprost Tromethamine—Nausea—Azathioprine—Crohn's disease	0.000738	0.00603	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RASGRP1—Crohn's disease	0.000738	0.000881	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Mesalazine—Crohn's disease	0.00072	0.00588	CcSEcCtD
Carboprost Tromethamine—Rash—Mesalazine—Crohn's disease	0.000714	0.00583	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Mesalazine—Crohn's disease	0.000713	0.00583	CcSEcCtD
Carboprost Tromethamine—Headache—Mesalazine—Crohn's disease	0.000709	0.00579	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Prednisone—Crohn's disease	0.000692	0.00565	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—JAK2—Crohn's disease	0.000684	0.000816	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SOCS1—Crohn's disease	0.000683	0.000815	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Mesalazine—Crohn's disease	0.000673	0.00549	CcSEcCtD
Carboprost Tromethamine—Angioedema—Prednisone—Crohn's disease	0.000671	0.00548	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—JAK2—Crohn's disease	0.00067	0.000799	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SOCS1—Crohn's disease	0.000669	0.000798	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Prednisone—Crohn's disease	0.000659	0.00539	CcSEcCtD
Carboprost Tromethamine—Syncope—Prednisone—Crohn's disease	0.000658	0.00538	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—TYK2—Crohn's disease	0.000651	0.000777	CbGpPWpGaD
Carboprost Tromethamine—Loss of consciousness—Prednisone—Crohn's disease	0.000645	0.00527	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—TYK2—Crohn's disease	0.000638	0.000761	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Prednisone—Crohn's disease	0.000634	0.00518	CcSEcCtD
Carboprost Tromethamine—Myalgia—Prednisone—Crohn's disease	0.000625	0.0051	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—Crohn's disease	0.000624	0.000745	CbGpPWpGaD
Carboprost Tromethamine—Anxiety—Prednisone—Crohn's disease	0.000623	0.00509	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—JAK2—Crohn's disease	0.000621	0.000741	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000611	0.000729	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—JAK2—Crohn's disease	0.000608	0.000726	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Prednisone—Crohn's disease	0.000599	0.00489	CcSEcCtD
Carboprost Tromethamine—Infection—Prednisone—Crohn's disease	0.000595	0.00486	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SMAD3—Crohn's disease	0.00059	0.000704	CbGpPWpGaD
Carboprost Tromethamine—Shock—Prednisone—Crohn's disease	0.000589	0.00481	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Prednisone—Crohn's disease	0.000585	0.00478	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Prednisone—Crohn's disease	0.000579	0.00473	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SMAD3—Crohn's disease	0.000577	0.000689	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—Crohn's disease	0.000567	0.000677	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—Crohn's disease	0.000555	0.000662	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL2RA—Crohn's disease	0.000546	0.000652	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000546	0.00446	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Prednisone—Crohn's disease	0.000538	0.00439	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL2RA—Crohn's disease	0.000535	0.000638	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Prednisone—Crohn's disease	0.000474	0.00387	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Prednisone—Crohn's disease	0.000441	0.0036	CcSEcCtD
Carboprost Tromethamine—Asthenia—Prednisone—Crohn's disease	0.00043	0.00351	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Prednisone—Crohn's disease	0.00041	0.00335	CcSEcCtD
Carboprost Tromethamine—Dizziness—Prednisone—Crohn's disease	0.000396	0.00324	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TYK2—Crohn's disease	0.000385	0.000459	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Prednisone—Crohn's disease	0.000381	0.00311	CcSEcCtD
Carboprost Tromethamine—Rash—Prednisone—Crohn's disease	0.000378	0.00309	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Prednisone—Crohn's disease	0.000377	0.00308	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TYK2—Crohn's disease	0.000377	0.000449	CbGpPWpGaD
Carboprost Tromethamine—Headache—Prednisone—Crohn's disease	0.000375	0.00307	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JAK2—Crohn's disease	0.000367	0.000438	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JAK2—Crohn's disease	0.000359	0.000429	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Prednisone—Crohn's disease	0.000356	0.00291	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—Crohn's disease	0.000335	0.0004	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—Crohn's disease	0.000328	0.000391	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—Crohn's disease	0.000319	0.00038	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—Crohn's disease	0.000312	0.000372	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STAT3—Crohn's disease	0.000269	0.000321	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STAT3—Crohn's disease	0.000264	0.000315	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—Crohn's disease	0.000188	0.000225	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—Crohn's disease	0.000184	0.00022	CbGpPWpGaD
